Safety and Efficacy of Rivaroxaban and Apixaban in Comparison to Warfarin in Left Ventricular Clot- Clinical Trial

NCT05973188 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

141

Enrollment

OTHER_GOV

Sponsor class

Conditions

Left Ventricular Thrombus

Interventions

DRUG: Warfarin
DRUG: Rivaroxaban 20 MG Oral Tablet
DRUG: Apixaban 5mg or 2.5mg oral tablet

Sponsor

Peshawar Institute of Cardiology

Collaborators

[object Object]